Orrin Devinsky MD, Director of the Comprehensive Epilepsy Center at New York University, was recently awarded FDA approval to conduct a clinical trial that will study the safety and tolerability of cannabidiol (CBD) in children with epilepsy.
CBD research is finding its way into the news more often. As clinical trials on CBD and epilepsy continue to conducted on the substance, Dr. Alan Shackelford — who oversaw the treatment of nine-month-old Kaitlyn Pogson‘s Dravet syndrome, a type of epilepsy that causes her to have 300 seizures per week (that’s one about every half hour of every day) — had this to say about administering high-CBD medical marijuana to the infant:
Industrial hemp, a cousin to the marijuana plant that is legal to import and consume in the United States, is naturally high in CBD and very low in THC.
Have a look at all the clinical trials being conducted on CBD and epilepsy at PubMed, a service of the National Institutes of Health. Read the full article about Kaitlyn Pogson’s plight and the potential of CBD at the Toronto Star.